Saruparib demonstrates early efficacy in breast cancers with DNA repair defects in Phase I/II trial

Medicine Research News ニュース

Saruparib demonstrates early efficacy in breast cancers with DNA repair defects in Phase I/II trial
Medicine ResearchHealth Research NewsHealth Research
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

The first-in-class PARP1-selective inhibitor saruparib demonstrated encouraging early efficacy and a favorable safety profile in patients with homologous recombination repair (HRR)-deficient breast cancers, according to results from the Phase I/II PETRA trial led by researchers at The University of Texas MD Anderson Cancer Center.

Saruparib demonstrates early efficacy in breast cancers with DNA repair defects in Phase I/II trial retrieved 8 April 2024 from https://medicalxpress.com/news/2024-04-saruparib-early-efficacy-breast-cancers.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Apr 18, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

medical_xpress /  🏆 101. in UK

Medicine Research Health Research News Health Research Health Science Medicine Science

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Barratt Homes Yorkshire East to launch second phase of Mortimer Park in DriffieldBarratt Homes Yorkshire East to launch second phase of Mortimer Park in DriffieldLocal housebuilder, Barratt Homes Yorkshire East, is set to unveil the first homes at the second phase of the Mortimer Park development where 120 additional homes are set to be built.
続きを読む »

Barratt Homes Yorkshire East to launch second phase of Mortimer Park in DriffieldBarratt Homes Yorkshire East to launch second phase of Mortimer Park in DriffieldLocal housebuilder, Barratt Homes Yorkshire East, is set to unveil the first homes at the second phase of the Mortimer Park development where 120 additional homes are set to be built.
続きを読む »

Planning application submitted for final phase of Newton Farm developmentPlanning application submitted for final phase of Newton Farm developmentThe application contains not only homes, but for two new primary schools and playparks, alongside much more.
続きを読む »

Bee Network's second phase launches today with buses in new areasBee Network's second phase launches today with buses in new areasThe second phase of the Bee Network was made official this morning in Oldham
続きを読む »

Get Ready for Occasionwear Season with Phase EightGet Ready for Occasionwear Season with Phase EightPhase Eight offers a wide range of occasionwear options for all body shapes and tastes. From wedding guests to racegoers, they have something for everyone.
続きを読む »

'The fear phase': Tomas Sala on landing another Falconeer game'The fear phase': Tomas Sala on landing another Falconeer gameChristian Donlan is a features editor for Eurogamer. He is the author of The Unmapped Mind, published as The Inward Empire in the US.
続きを読む »



Render Time: 2025-03-23 15:53:20